Skip to main navigation Skip to search Skip to main content

Climate change as a challenge for pharmaceutical storage and tackling antimicrobial resistance

  • Omololu E. Fagunwa*
  • , Diane Ashiru-Oredope
  • , Brendan F. Gilmore
  • , Simon Doherty
  • , Linda B. Oyama
  • , Sharon A. Huws
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    10 Citations (Scopus)

    Abstract

    The rise of antimicrobial resistance (AMR) remains a pressing global health challenge. Infections that were once easily treatable with first-line antimicrobials are becoming increasingly difficult to manage. This shift directly threatens the wellness of humans, animals, plants, and the environment. While the AMR crisis can be attributed to a myriad of factors, including lack of infection prevention and control measures, over-prescription of antimicrobials, patient non-compliance, and the misuse of antimicrobials, one aspect that has garnered less attention is the role of storage conditions of these medicines. The way medications, particularly antimicrobials, are transported and stored until the point of use can influence their efficacy and, subsequently, may impact the development of resistant microbial strains. This review delves deeper into the often-overlooked domain of climate change (CC) and antimicrobial storage practices and the potential effects. Inappropriate storage conditions, such as exposure to extreme temperatures, humidity or light, can degrade the potency of antimicrobials. When these compromised medicines are administered to patients or animals alike, they may not effectively eradicate the targeted pathogens, leading to partial survival of the pathogens. These surviving pathogens, having been exposed to sub-lethal doses, are more likely to evolve and develop resistance mechanisms. The review discusses the mechanism underlying this and underscores the implications of antimicrobial storage practices in relation to two of the most pressing global health challenges: AMR and CC. The review also presents specific case studies and highlights the importance of monitoring storage practices and supply chain surveillance. Furthermore, the importance of deploying genomic tools to understand the potential impact of storage conditions on the development of AMR is discussed, and antimicrobial storage highlighted as a crucial part of comprehensive strategies in the fight against AMR.

    Original languageEnglish
    Article number177367
    JournalScience of the Total Environment, The
    Volume956
    DOIs
    Publication statusPublished - 15 Dec 2024

    Bibliographical note

    Publisher Copyright:
    © 2024 The Authors

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 13 - Climate Action
      SDG 13 Climate Action

    Keywords

    • Antibiotics
    • Antimicrobial resistance
    • Climate change
    • Horizontal gene transfer
    • One health
    • Pharmaceutical supplies

    Fingerprint

    Dive into the research topics of 'Climate change as a challenge for pharmaceutical storage and tackling antimicrobial resistance'. Together they form a unique fingerprint.

    Cite this